Molecular profiling demonstrates that the ABC-Myc hepatoblastoma resembles high-risk human disease, making this model helpful for understanding the mechanisms of tumorigenesis and for testing therapy response in high-risk hepatoblastoma. This evidence concerns the gene MYC and hepatoblastoma.